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ABSTRACT: The use of hybrid self-assembling peptide (EFK8)-carbon nanotube (SWNT) 
hydrogels for tissue engineering and in vitro 3D cancer spheroid formation is reported. These 
hybrid hydrogels are shown to enhance the attachment, spreading, proliferation and movement of 
NIH-3T3 cells relative to that observed using EFK8-only hydrogels. After five days, ~30% more 
cells are counted when the hydrogel contains SWNTs. Also, 3D encapsulation of these cells 
when injected in hydrogels does not adversely affect their behavior. Compressive modulus 
measurements and microscopic examination suggest that SWNTs have this beneficial effect by 
providing sites for cell anchorage, spreading and movement rather than by increasing hydrogel 
stiffness. This shows that the cells have a particular interaction with SWNTs not shared with 
EFK8 nanofibers despite a similar morphology. The effect of EFK8 and EFK8-SWNT hydrogels 
on A549 lung cancer cell behavior is also investigated. Increasing stiffness of EFK8-only 
hydrogels from about 44 Pa to 104 Pa promotes a change in A549 morphology from spheroidal 
to a stretched one similar to migratory phenotype. EFK8-SWNT hydrogels also promote a 
stretched morphology, but at lower stiffness. These results are discussed in terms of the roles of 
both microenvironment stiffness and cell-scaffold adhesion in cancer cell invasion. Overall, this 
study demonstrates that applications of peptide hydrogels in vitro can be expanded by 
incorporating SWNTs into their structure which further provides insight into cell-biomaterial 
interactions. 
 
Keywords: self-assembling peptides, carbon nanotubes, hydrogels, tissue engineering, tumor 
microenvironment  
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1.   Introduction 
Hydrogels are commonly used biomaterials for tissue engineering and 3D cell cultures due to 
their high biocompatibility and the similarity of their physical and mechanical properties to that 
of living tissue [1]–[5]. These properties provide a compatible environment for cells and enable 
their behavior to be similar to that observed in vivo. Hydrogels can also be modified chemically 
to mimic living tissues so that they become more biocompatible and enhance their in vivo 
performance [1]–[3], [6]. 
Different types of materials have been used so far to make hydrogel scaffolds. Synthetic 
materials such as polylactic acid (PLA) [7], [8], polyethylene oxide (PEO) [9], polyglycolic acid 
(PGA) [10], polyvinyl alcohol (PVA) [11], [12], polyethylene glycol (PEG) [13], organosilica-
based nanocomposites [14], [15]  as well as polysaccharide hydrogels including hyaluronic acid 
(HA) [16], chitosan [17], agarose [18] and alginate [19] have been investigated for use with 
different types of tissues. Production of these synthetic polymers is reproducible which makes 
them attractive for researchers. However, hydrogels formed this way have major drawbacks such 
as large fiber/pore sizes, the use of toxic reagents for gel formation, low degradation under 
physiological conditions, improper charge density, low nutrient diffusion rate and acidic 
products due to degradation [20]. On the other hand, protein-based hydrogels using collagen 
[21], gelatin [22], fibrin [23], elastin [24], silk fibroin [25] and MatrigelTM are more 
biocompatible and biodegradable and provide a better platform for cell attachment and growth. 
However, they suffer from batch-to-batch variations and unwanted contaminants such as growth 
factors, proteins and viruses which can interfere with cell function [1], [20]. On the whole, the 
best option would be to use a synthetic material composed of naturally occurring components. 
Self-assembling peptides are very promising from this point of view. They are formed from 
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amino acids found ubiquitously in the body; at the same time, they can be synthesized with 
precise control of its chemical composition. This should minimize the effects of contaminants 
and enable the distinction between the effects of different cues on cell behavior in the prepared 
scaffold. Their biodegradation products are natural amino acids that are safe to cells and can be 
functionalized with different bioactive motifs for different cells and tissues. Also nano-sized 
fibers and pores of these hydrogels mimic the structure of living tissues in vivo. This provides an 
environment that can simulate in-vivo cell-cell and cell-scaffold interactions. In addition, fiber 
crosslinking by which hydrogels form from these peptides does not require any chemical 
additives, UV irradiation or heat treatment which can lead to lower cell biocompatibility, unlike 
the situation with other biopolymer-based hydrogels. Finally, these peptide hydrogels can be 
formed by injection which enables them to encapsulate cells for 3D cultures and be used in vivo 
with minimum need for surgery [26]. 
To date, different types of self-assembling peptide hydrogels have been used for biomedical 
applications ranging from hydrogels for tissue engineering  [27][28] to nano-vehicles for anti-
cancer drug and si-RNA delivery [29]. RADA16-I (RADARADARADARADA) hydrogels with 
the commercial name of PuraMatrixTM  have been used as scaffolds in cell cultures [20]. The 
advantage of this peptide compared with other self-assembling peptides such as EFK8 
(FEFEFKFK) is its similarity to the RGD (arginine-glycine-aspartic acid) tripeptide, a sequence 
within fibronectin that allows for cell attachment. Furthermore, the sequence of this peptide has 
been modified to extend its functionality and range of cells that can be seeded [30]. However, its 
mechanical strength drops after neutralization to the physiological pH which leads to its 
disruption when subjected to stress [31]. EFK8 is another type of self-assembling peptide with 
better mechanical strength due to stronger hydrophobic interactions conferred by the presence of 
phenylalanine [32]. Strong hydrophobic interactions, electrostatic and van der Waals’ forces as 
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well as hydrogen bonding are the forces that drive EFK8 self-assembly. We have previously 
shown that EFK16-II and EFK8 peptides can disperse carbon nanotubes and be combined to 
form hybrid peptide-CNT hydrogels upon adding millimolar concentrations of monovalent salts 
[33], [34]. Although the suitability of CNTs and other carbon nanomaterials for biomedical 
applications is still an open question, many research studies have focused on their use in 
scaffolds for biomedical applications [35]–[51]. 
Another important application of hydrogels is for 3D cell cultures. Hydrogels have been used as 
3D scaffolds for drug discovery and 3D cancer tumor studies in vitro [4], [5], [52]. A 3D 
environment changes the behavior (e.g. growth rate, morphology and drug resistance) of cultured 
cell lines compared to that of 2D environments, enabling cell behavior that more closely mimics 
that occurring in vivo [4], [53]–[56]. Both the extracellular matrix (ECM) and the physical 
properties of the microenvironment contribute significantly to the behavior and gene expression 
of cancer cells when they are in vivo. In contrast with the classical theory of cancer which posits 
accumulated gene mutations to be the main cause of cancer, tissue organization field theory 
(TOFT) introduces the cell-microenvironment interaction as the starting point for cancer 
[57][58]. It has even been reported that the placement of malignant tumor cells in a normal 
microenvironment can revert the cancer cells to a normal phenotype [59], [60]. With this 
approach, not only the tumor microenvironment can be a target for cancer therapy [61] but also 
bio-mimetic 3D scaffolds can serve as useful models of healthy ECM to treat the tumors in vivo 
and avoid the local formation of new tumors [52], [57], [62]. For these reasons, attention in 
recent years has been increasingly focused on the tumor microenvironment as an important 
controlling factor for cancer. 
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Although treatment of tumors through surgery, chemotherapy and radiation has progressed 
tremendously, the ability to accurately predict the metastatic potential of a tumor is still missing 
[63]. It has been well documented that tuning the scaffold stiffness can affect the growth and 
differentiation of different types of cells [64]–[69]. Stiffness has been shown to be an important 
characteristic of the microenvironment that affects tumor formation, progression and metastasis 
[70], [71]. Microenvironment stiffness can affect cell proliferation and differentiation so that the 
cells become metastatic [63], [72]–[74]. Thus, synthetic scaffolds with tunable compressive 
modulus can serve as useful artificial 3D microenvironments to study cancer cells, spheroids and 
tumors [75]–[79]. 
In the current work, we have investigated the effect of the presence of SWNTs in EFK8 
hydrogels on the NIH-3T3 fibroblast cell adherence, proliferation, movement and spreading in 
vitro as well as the hydrogel compressive modulus. Also, the potential of EFK8 as a 3D scaffold 
with tunable compressive modulus to study A549 lung cancer cell spheroid formation in vitro 
has been examined. A549 cells were chosen due to similarity of the compressive modulus of the 
hydrogels to that of human lung tissue (< 1 kPa [80]). Finally, the effect of SWNT on the 
behavior of the cancer cells is investigated.  
2.   Materials and Methods 
2.1   Materials 
The ionic complementary peptide EFK8 with a sequence of FEFEFKFK was used in this study. 
This peptide was synthesized in our laboratory using an Aapptec Apex 396 peptide synthesizer 
Aapptec LLC (Louisville, KY, USA). The peptide was protected by acetyl and amino groups at 
the N terminus and C-terminus, respectively, to prevent end-to-end electrostatic interactions 
between peptides. In the peptide synthesis, cleavage was performed for 2h using the following 
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cleavage mixture: TFA (trifluoroacetic acid): TIS (Triisopropylsilane): water (95:2.5:2.5 volume 
ratio). Synthesis scale was based on one gram of resin and molar excess used during synthesis 
was 4.  EFK8 was dissolved in pure water (18.2 MΩ ; Millipore Milli-Q system) at a concentration 
of 2.5 mg ml−1 to prepare the peptide stock solution and then stored at 4°C before use. The 
metallic SWNTs (carbon > 90%, carbon as SWNT > 77%) were purchased from Sigma-Aldrich 
Co (catalog# 727777, lot# MKBH7136V). NIH-3T3 and A549 cells were purchased from 
ATCC. DMEM (high glucose) and F12-K medium solutions as well as fetal bovine serum (FBS) 
were obtained from HyCloneTM. Penicillin/streptomycin mixtures containing 10000 units 
penicillin and 10 mg streptomycin, FluoroshieldTM with DAPI and anti-β-catenin antibody 
produced from rabbits (C2206) were acquired from Sigma-Aldrich (Canada). Actin GreenTM 488 
ReadyProbes® reagent and Calcein AM (C3099) were purchased from Life Technologies. 
AffiniPure Donkey anti-Rabbit IgG (Jackson Immunoresearch laboratories Inc, West Grove, PA, 
USA) was used as the secondary antibody.  
2.2   Methods 
2.2.1   Peptide synthesis 
All amino acids (Fmoc protected), activator 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-
tetramethylaminium hexafluorophosphate (HCTU) and Rink Amide-AM resin were obtained 
from Aapptec LLC. All other solutions were purchased from Acros Organics (NJ, USA). The 
EFK8 peptide with a molecular weight of 1162.60 g mol−1 was synthesized using the solid-phase 
peptide synthesis (SPPS) method using an Aapptec Apex 396 peptide synthesizer (Aapptec LLC, 
USA) and then purified by repeated precipitation in cold ether. The resulting peptide was then 
freeze-dried to yield a powder that was stored at 4°C. Matrix-assisted laser desorption ionization 
time-of-flight mass spectroscopy (MALDI-TOF MS) (Q-TOF Ultima Global, Waters, Milford, 
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MA, USA) was used to measure the molar mass of the synthesized peptide. Also high-
performance liquid chromatography (HPLC) was employed to measure the purity of the peptide 
samples used in this study, which is found to be 72% (Fig. S1).     
2.2.2   SWNT dispersion preparation 
The stock suspensions were prepared by combining EFK8 and as-received SWNT (carbon > 
90%, carbon as SWNT > 77%) together at a 1:1 mass ratio in pure water (18.2 MΩ ; Millipore 
Milli-Q system) to yield concentrations of 0.5 mg ml−1 of both the peptide and SWNTs. Previous 
research in our laboratory has shown that the critical aggregation concentration of EFK8 in these 
EFK8-SWNT suspensions is below 0.1 mg/ml and these suspensions exhibit a zeta potential of ~ 
56 mV [33]. The suspensions were then mixed for 1 hour using a Qsonica XL-2000 probe 
sonicator at a power of 10W and centrifuged at a speed of 2000 × g for 1h to separate the 
supernatant from the solids. Afterward, the supernatant was isolated for later use in hydrogel 
formation. It was also important to determine the EFK8 and SWNT concentration remaining in 
this supernatant since it was being used for hydrogel formation. To do this, we prepared 10 ml of 
the EFK8-SWNT suspension (with initial concentration of 0.5 mg/ml for both EFK8 and SWNT) 
and used a freeze-drying method to obtain dry material for thermogravimetric analysis (TGA). 
This involved freezing the dispersion for 24h at -80°C and then freeze-drying it for four days to 
remove the water content and leave behind a peptide-SWNT mixture. The composition of this 
freeze-dried mixture was then estimated by TGA over the temperature range from 25°C to 
1000°C in a nitrogen atmosphere. As reported in a number of TGA analyses reported in the 
literature [81][82][83][84], peptides typically begin to thermally decompose at temperatures 
between 200°C and 300°C, and disappear completely before 600°C whereas SWNTs only begin 
to decompose at temperatures close to ~ 600°C. This behavior was supported by our TGA data 
  
9 
 
which showed a continuous mass loss beginning at 231°C up to 580°C (with a DTG peak at 
~240.4°C) followed by a plateau in mass at temperatures between 580°C and ~ 648.5°C and then 
a resumption in mass loss above 648.5°C until the end of the experiment at 1000°C (Fig. S2). 
Based on this, we estimated the mass of EFK8 peptide and SWNT initially present in the freeze-
dried peptide-SWNT mixture from the difference in the initial mass of the freeze-dried 
supernatant and the loss of mass as the sample was heated from 231°C to 580°C. From 
measurement of the weight loss, we determined that the EFK8 and SWNT concentration in the 
supernatant of a 0.5 mg/ml EFK8-SWNT dispersion was 0.12 mg/ml and 0.14 mg/ml 
respectively. 
2.2.3   Hydrogel formation 
Transparent PET membrane inserts with 1.0 µm pore size (BD Biosciences, San Jose, CA) were 
placed in 24-well cell culture plates. Then EFK8 and EFK8-SWNT solutions with the EFK8 
concentration of 1.25 mg ml−1 were added to the inserts and cell culture medium was injected 
into the space between each insert and the well wall. Once monovalent salts present in the 
medium diffuse across the insert membrane, hydrogel formation was triggered through peptide 
charge screening by salt ions. The solutions were left exposed to UV light for 30 min at room 
temperature inside the biosafety hood to ensure sterilization of the hydrogel. To equilibrate the 
hydrogel with the medium, 400 µl of the cell culture medium was layered on top of the hydrogel 
and the plates transferred to a 37.0°C incubator. After an hour, two-thirds of the medium was 
gently removed and replaced with 400 µl of fresh medium before being placed in the 37.0°C 
incubator for another 1h. Finally, the medium in the insert was replaced and the medium in the 
well below the insert was replaced with 800 µl fresh medium and the plate was left in the 
incubator overnight. 
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2.2.4   Cell culture 
Mouse NIH-3T3 fibroblast cells (12000 cells/well) were cultured on hydrogels formed in the 24-
well inserts in the presence of Dulbecco's Modified Eagle's medium (DMEM, high glucose) with 
10% fetal bovine serum and 1% penicillin/streptomycin (pH 7.4) and then transferred to an 
incubator containing 5% CO2 at 37.0°C. Medium on top of the hydrogel and inside the wells was 
changed every 2-3 days. Human A549 lung cancer cells cultured in F12-K medium containing 
10% FBS and 1% penicillin/streptomycin (pH 7.4) and maintained as described above.  
2.2.5   Morphological and immunostaining 
Calcein AM (8µM) was added to the cells and left for 30 min for morphological staining. To 
carry out staining, the medium was gently removed from the inserts and the cells were fixed in 
4% paraformaldehyde for 20 minutes at room temperature, washed 3 times with PBS and the 
cells were permeabilized with 0.5 wt% Triton X-100 for 10 min. Then the hydrogels were 
washed three times with PBS. To reveal the actin cytoskeleton, one droplet of Actin GreenTM 
probe was added to the hydrogel and left for 30 min followed by washing 3 times with PBS. 
FluoroshieldTM with DAPI was added to stain nuclei and left for 1 hour to penetrate into the 
hydrogel followed by 3 sequential washes of the surface with PBS. Also hydrogels were 
incubated in the blocking solution (PBS solution containing 10% fetal bovine serum) for 12-16 
hours and fixed cells were stained for cell-cell junctions using anti- β-catenin (rabbit anti-β-
catenin) at an anti- β-catenin antibody: blocking solution ratio of 1:500 and incubated at 4°C 
overnight. After washing the hydrogels with blocking solution four times (two hours per wash), 
the secondary antibody (donkey anti-rabbit IgG) was added to the blocking solution at a ratio of 
1:250 and contents incubated for four hours. After three washes with PBS, the hydrogels were 
incubated in FluoroshieldTM with DAPI for 1h and washed three final times with PBS.  
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 2.2.6   3D cell encapsulation 
Stock EFK8 solution (5 mg ml−1) was diluted 1:1 with sterile 20% w/v sucrose in H2O. NIH-3T3 
cells were washed 2 times in 10% w/v sucrose in H2O, re-suspended in 10% sucrose to yield a 
density of 8×105 cell/well. The cell suspension was quickly mixed with an equal volume of the 
EFK8/10% sucrose solution to generate a final cell suspension (4×105 cell/ well) in EFK8 (1.25 
mg ml−1) and 10% sucrose. A 24-well plate was prepared with 250 µl of tissue culture 
medium/well. 100 µl of the cell suspension was added into each well insert. After five min, 400 
µl tissue culture medium was gently layered over the gelled hydrogels. Plates were placed in the 
37.0°C incubator and the medium was changed following the same procedure used to form the 
hydrogels (section 2.2.3). Experiments were repeated three times for each sample. 
2.2.7   Microscopy 
Images were taken using an EVOS fl digital inverted microscope (Life Technologies, USA) after 
1, 3 and 5 days of incubation. For confocal imaging, the hydrogels were removed from the 
inserts and placed in chambered cover glasses facing (apical surface) down. PBS was added to 
prevent the hydrogels from drying during imaging. Confocal images were taken using a Zeiss 
LSM 510 Meta Confocal Microscope (Zeiss, Germany). The hydrogel samples were dried prior 
to SEM imaging by successive immersions in 30%, 50%, 70%, 90% and 100% ethanol solutions 
over a 2-day period. Once dehydrated, the hydrogels were prepared for microscopy using a 
custom-made critical point drier (CPD) employing supercritical CO2. Scaffolds were fixed on 
aluminum stubs using carbon paste and gold sputtered for 100 sec prior to imaging using an FE-
SEM (LEO 1530) unit. Again, experiments were repeated three times for each sample. 
2.2.8   Micro-indentation 
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The compressive moduli of the hydrogels were measured using a micro-indenter equipped with a 
0-25 g load cell (GSO-25, Transducer Techniques, CA, USA) and a hemispherical (D: 6mm) 
PDMS probe at a maximum load of 1g and speed of 5µ/s. Once again, experiments were repeated 
three times for each sample. The compressive modulus was calculated from the slope of the 
resulting stress-strain curve over the linear portion from 0 to 5% strain. 
3. Results and Discussion 
3.1   Effect of SWNT on cell attachment, spreading and proliferation 
NIH-3T3 cells were seeded on the EFK8 hydrogel. Figure 1a-c show that NIH-3T3 cells that 
were initially spread over the surface of the EFK8 hydrogel tended to coalesce into colonies. As 
the colonies increase in size, the areas between them become almost free of cells. The cells that 
remain outside of the colonies display a rounded phenotype suggesting they adhere poorly to the 
hydrogel and form colonies due to the more favorable cell-cell adhesion over cell-hydrogel 
adhesion.  
NIH 3T3 cells seeded on EFK8-SWNT hydrogels attach and spread more evenly across the 
hydrogel surface (Figure 1d-f). Most of the cells have a spindle-like morphology characteristic of 
NIH 3T3 cells. This demonstrates that the hybrid hydrogel provides a more suitable scaffold for 
the cells to attach and spread. Since the only difference between the hydrogels is the presence of 
SWNTs in the EFK8 scaffold, it is likely that this moiety provides sites that mediate cell 
attachment. This is in agreement with the previous reports on the effect of carbon-based 
nanomaterials such as CNTs and graphene on the cell behavior due to their strong affinity with 
the cells and specially as a result of their aromatic structure which can increase the local 
concentration of ECM proteins such as collagen, laminin and fibronectin [85][86]. We have 
previously shown that when EFK8 peptides interact with SWNTs, they tend to wrap around them 
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with a helical pattern [34]. This helical pattern should still leave some portions of SWNT 
accessible for the cells to reach. Although not included here, we found that the cells did not 
exhibit any change in behavior when the SWNT concentration used to generate the hydrogels 
was decreased four-fold. Although CNTs have been found to enhance cell attachment, 
proliferation and differentiation, the mechanism by which they interact with cells has not been 
investigated and is beyond the scope of this study. Nevertheless, it is worth noting that the 
gelation of these self-assembling peptides is driven by neutralization of their electrostatic charge 
promoted by monovalent salt ions present in the cell culture medium. Thus, we would expect the 
overall charge of both the EFK8 and EFK8-SWNT hydrogels to be zero [87][88]. Thus, the 
differences in the cell behavior in the presence of these two hydrogels cannot be correlated to 
differences in hydrogel charge. The confocal microscopy images in Figure 1g and h show NIH 
3T3 cells after 3 days incubation on EFK8 and EFK8-SWNT hydrogel, respectively. In these 
higher magnification images, the difference in the cells in these two environments is more 
obvious. The cells on EFK8 clearly form clusters with actin accumulating along the cell 
boundaries, while they are more spread out on EFK8-SWNT and actin is arranged in stress fibers 
indicative of strong substrate adhesion.  
Also Figure1i shows cells seeded on RADA16-I hydrogel as a control sample. The resulting 
image shows that the hydrogel is disrupted after one day and cannot maintain its initial shape 
which can hinder its application for transplanting in-vivo, although the cells can attach and 
proliferate very well with a spindle-like morphology on the RADA16-I hydrogel (due to 
similarity of the peptide sequence to RGD), in agreement with that reported in the literature [31]. 
Figure 2 presents SEM images of fixed cells on the hydrogels. These images show that cells 
move on the EFK8 hydrogel to form small clusters (Figure 2a). From the higher magnification 
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image in Figure 2b, the aggregation of cells into small colonies is very apparent. On the other 
hand, when cells are seeded on the EFK8-SWNT hydrogel, they remain dispersed and display a 
classic spindle-shaped morphology (Fig 2c). Higher magnification images of an individual cell 
on the hybrid EFK8-SWNT hydrogel are shown in Figure 2c-f. Cells display both lamellipodia 
(Figure 2d, e) as well as numerous filopodia (Fig 2e, f), indicative of their strong adhesion to the 
hybrid hydrogel.  
The different cell behavior shown in Figure 1 suggests that cells proliferate faster on the EFK8-
SWNT hydrogel and more cells are living in this scaffold after 5 days. To compare the 
proliferation rate of cells seeded on the two hydrogels, the gels were disrupted and the cells 
collected and mixed with trypan blue. Live cells were counted using a hemocytometer after 1, 3 
and 5 days of culture (Figure 3a). The cell viability was found to be more than 90% in all 
samples except for EFK8 at day one which may be due to the higher number of non-attached 
cells on the hydrogel that have died (Figure 3b). However this analysis shows that the number of 
cells is similar on both hydrogels one day after seeding. But, over the period from day one to day 
three after seeding, cells proliferate at a higher rate on the hybrid hydrogel. The difference in the 
proliferation rate of cells continues to diverge over the period from day three to day five (Figure 
3a).  
Thus, based on these microscopy images and cell counting data, the presence of SWNTs in the 
EFK8 hydrogel appears to alter cell behavior so that cell attachment, spreading and proliferation 
rate is enhanced.  
3.2   Effect of SWNT on cell movement 
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To better investigate cell movement in the two types of hydrogels, a small droplet of EFK8-
SWNT dispersion was placed on the EFK8 solution and then gelation was triggered 
simultaneously in both of the hydrogels. In this way, isolated hybrid EFK8-SWNT hydrogels 
were distributed over the surface of the EFK8 hydrogel. The sample was then examined using 
light and confocal microscopy. Figure 4a is a transmitted light image showing stretched cells 
populating an isolated EFK8-SWNT hydrogel surrounded by cell colonies on the EFK8 hydrogel 
three days after seeding cells. This clearly shows the contrast between the stretched morphology 
that cells can assume in the hybrid hydrogel and the rounded shapes in the colonies that form 
when the hydrogel consists of EFK8 alone. A confocal image of the same region better 
highlights the difference in cell morphology on the two portions of the surface (Figure 4b). 
Three-dimensional reconstruction of confocal images clearly demonstrates the difference in the 
adhesive properties of the two hydrogels. Figure 4c and d show reconstructed 3-dimensional 
images of these cells at two different angles. Although cells were originally seeded only on the 
very top of the hydrogel, cells appear to have penetrated vertically into the hydrogel. This effect 
further depicts the role of CNT in improving cell-scaffold interactions and enhancing cell 
movement. 
3.3   3D encapsulation of cells inside hydrogels 
One of the major applications of hydrogels in tissue engineering is to encapsulate and deliver 
cells to a desired target in-vivo. Typically, the hydrogel is transplanted into the injured area after 
surgery to gain access. However, an advantage of injectable hydrogels is the minimal wound 
produced during cell transplantation. To do so, cells should be already encapsulated in the 
hydrogel precursor dispersion prior to injection. To test this idea, cells were dispersed in EFK8 
and EFK8-SWNT dispersions and hydrogels formed. Figure 5 presents optical images of cells in 
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EFK8 and EFK8-SWNT hydrogels after one, three and five days of encapsulation. As can be 
seen, cells show similar behavior to that observed previously when they were seeded on top of a 
pre-existing EFK8 and hybrid hydrogel (Figure 1). In the EFK8 hydrogel, cells stretch and move 
toward each other to form colonies over the period from day one to day five (Figure 5a-c). Once 
again, this result indicates that cells cannot anchor and adhere very well to the scaffold in this 
hydrogel and show the natural morphology of fibroblast cells. The images obtained on the hybrid 
hydrogel (Figure 5d-f) show that no significant difference between cell morphologies is observed 
in the two types of hydrogels on day one. However, the behavior changes thereafter as the cells 
exhibit stretched morphology and spread well inside the hybrid hydrogel by days three and five. 
These results also demonstrate that embedding NIH-3T3 cells in the EFK8-SWNT hydrogel has 
no adverse effect on cell viability and behavior.  
3.4   Compressive modulus of hydrogels 
The compressive moduli of EFK8 hydrogels formed at different peptide concentrations as well 
as the hybrid EFK8-SWNT hydrogel are presented in Figure 6a. As can be seen, an increase in 
the peptide concentration raises the modulus of the EFK8 hydrogel. Also, a comparison of results 
obtained for the EFK8 and EFK8-SWNT hydrogels formed from the same peptide concentration 
of 1.25 mg ml−1 shows that the presence of SWNT in the EFK8 hydrogel does not significantly 
change its modulus. This can be attributed to the very low concentration of SWNTs in the 
hydrogel. Thus, the previously noted difference in the cell behavior on these two hydrogels is not 
likely caused by a change in the stiffness, as has been reported in some previous studies [64]–
[69]. This trend supports the conclusion that the difference is due to the ability of SWNT itself to 
provide appropriate sites for cell anchorage. This result is further confirmed by observation of 
the behavior of NIH-3T3 cells cultured on a stiffer EFK8 hydrogel formed from a peptide 
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concentration of 5 mg ml−1. On the other hand considering similar morphology of peptide 
nanofibers and SWNTs in the hydrogel reveals that the cells have a particular interaction with 
SWNTs which is not shared with EFK8 nanofibers. The image of these cells taken after five days 
and shown in Figure 6b does not show any distinctive difference in the cell morphology on this 
hydrogel and the less stiff EFK8 hydrogel formed from 1.25 mg ml−1 previously presented in 
Figure 1c. The cells form colonies even on this stiffer hydrogel, whereas the cell morphology is 
very different when cultured on the hybrid EFK8-SWNT hydrogel. 
3.5   EFK8 and EFK8-SWNT hydrogels as scaffolds for engineering cancer cell spheroids 
In the final stage of this study, A549 lung cancer cells were seeded on the hydrogels to evaluate 
the suitability of EFK8 and EFK8-SWNT hydrogels as 3D cell culture platforms to study the 
formation of spheroidal cancer cells. As can be seen in Figure 7 (left column), cancer cells grow 
over time and form spheroidal colonies on an EFK8 hydrogel. Furthermore, these tumor-like 
spheroids grow over time on the hydrogel. This shows that an EFK8 hydrogel can be used as a 
3D cell culture platform triggering cancer cells to form spheroids which is more similar to the 
morphology of real tumors than that obtained with 2D cell cultures.  
To explore whether the compressive modulus of the hydrogel has any effect on the behavior of 
the cancer spheroids, A459 cells were seeded on a stiffer EFK8 hydrogel formed from 5 mg ml−1 
peptide solution. The optical images shown in Figure 7 (middle column) indicate that increasing 
the compressive modulus from about 44 Pa to 104 Pa leads to more stretched cells with a higher 
potential for spreading and movement, demonstrating the role of microenvironment stiffness in 
cancer cell invasion. This contrasts with the NIH-3T3 cell behavior on the stiffer hydrogel that 
shows no dependence on change in hydrogel compressive modulus. This reflects that the 
threshold of sensitivity to scaffold stiffness may vary from cell to cell. Interestingly, as shown in 
  
18 
 
the right column of Figure 7, the addition of SWNTs to the EFK8 hydrogel formed from 1.25 mg 
ml−1 peptide leads to similar cell morphology (stretched cells with long protrusions) to that 
observed on EFK8 alone when formed from 5 mg ml−1 peptide. Earlier in this study, we showed 
that the presence of SWNTs in an EFK8 hydrogel improved normal cell attachment, spreading 
and movement. Thus, the behavior of A549 cells when seeded on EFK8-SWNT likely reflects 
the effect that binding regions in the tumor microenvironment and cell-biomaterial interaction (in 
addition to that of compressive modulus) have on cancer metastasis. 
Figure 8a, b shows cells that have been stained using the Calcein AM on EFK8 hydrogels 
formed from both 1.25 and 5 mg ml−1 peptide. In Figure 8a the green color of Calcein AM is 
replaced with a spectrum of different colors that represent different distances from the hydrogel 
surface to better reflect the 3D character of the spheroids. These images show that the cells have 
spheroidal geometry when grown on the hydrogel formed at 1.25 mg ml−1 peptide (Figure 8a) 
and stretched morphology when grown on the hydrogel formed at the higher peptide 
concentration (Figure 8b). Immunostaining for β -catenin, which is normally concentrated at the 
cell-cell junctions, and of the cell nucleus using DAPI was also conducted. Figure 8c shows that 
cells seeded on the EFK8 hydrogel formed from 1.25 mg ml−1 peptide form spheroids that pack 
together with sharp polygonal boundaries, characteristic of compact cells in colonies, and have 
concentrated green β -catenin color on the edges. In the case of the EFK8 hydrogel formed from 5 
mg ml−1 peptide (Figure 8d) and the EFK8-SWNT hydrogel (Figure 8e), although similar 
polygonal boundaries can be seen in some parts (specially on the first hydrogel), but some cells 
at the border of the spheroids have stretched morphology, contain less concentrated β -catenin on 
the edges and do not have sharp polygonal boundary. This suggests that these cells are not 
strongly attached to their neighbor cells which should facilitate colony dissociation and 
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individual cell movement. This is apparent from the morphology of some of the cells especially 
on the hybrid hydrogel.  
4.   Conclusions 
It was shown that the presence of SWNTs in the EFK8 hydrogel significantly increases NIH-3T3 
cell attachment and leads to a spindle-like morphology, an indication of healthy cells. Also, cells 
proliferate faster on the SWNT-containing hydrogel. It was observed that cells spread evenly and 
move more on the hybrid hydrogel than on an EFK8 hydrogel, both in 2D and 3D cultures. This 
contrast in cell behavior may be useful for cell patterning in future work. Furthermore, EFK8-
SWNT is able to encapsulate the cells for use in delivery applications, while the presence of 
SWNTs in the hydrogel did not hinder the cell behavior observed in 2D cultures. An increase of 
the peptide concentration was found to raise the compressive modulus of the resulting hydrogels. 
However, the presence of the SWNT in the EFK8 hydrogel did not have an effect on its 
compressive modulus. Also, culturing the cells on a stiffer hydrogel made no significant 
difference to the apparent behavior of NIH-3T3 cells. Thus, we conclude that the improvement in 
NIH-3T3 cell attachment, growth, spreading and movement on the hybrid hydrogel is not related 
to the change in modulus and instead is probably related to the enhanced cell-scaffold 
attachment. Considering similar morphology of peptide fibers and SWNTs in the hydrogel, this 
shows that SWNTs have a particular interaction with the cells which is not shared by the EFK8 
nanofibers. EFK8 hydrogels can also be used as 3D cell culture scaffolds for cancer cells. They 
were found to promote formation of A549 cancer cell spheroids which grow by time and can be 
used for 3D drug screening. In contrast with the NIH-3T3 cell behavior, an increase in the 
compressive modulus of the hydrogel leads to A549 cells with a more stretched morphology and 
able to move more easily over the surface, demonstrating the role of microenvironment stiffness 
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in cancer cell invasion. This also shows that different cells may have different thresholds of 
sensitivity to the scaffold stiffness. On the other hand, the addition of SWNTs to the EFK8 
hydrogel (while keeping its modulus unchanged) results in cells with mobility similar to that 
observed on stiffer hydrogels, signifying the importance of cell-scaffold interactions to 
metastasis. Finally this study demonstrates that incorporating SWNTs into peptide hydrogels can 
expand applications of these hydrogels in tissue engineering and can give further insight into 
cell-biomaterial interactions. 
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List of Figures: 
 
Figure 1. NIH-3T3 cells seeded and cultured on EFK8 hydrogel after (a) 1, (b) 3 and (c) 5 days of 
seeding and on EFK8-SWNT hybrid hydrogels after (d) 1, (e) 3 and (f) 5 days of seeding (scale bar: 400 
µm). Confocal microscopy images of (g) EFK8 and (h) EFK8-SWNT at higher magnification (scale bar: 
20 µm). Cells were stained for f-actin using Actin GreenTM (green) and for nuclei with DAPI (blue)). (i) 
RADA16-I hydrogel disrupted one day after seeding the cells (scale bar: 1000 µm). 
 
Figure 2. (a-b) NIH-3T3 cell colonies on EFK8 hydrogel at different magnifications. (c-f) Individually 
spread cells on the hybrid EFK8-SWNT hydrogel at different magnifications. Cell protrusions responsible 
for cell attachment to the scaffold are apparent in (f).    
 
Figure 3. (a) NIH-3T3 cell proliferation on the EFK8 and EFK8-SWNT hydrogels  incubated for one, 
three and five days after seeding. All data represent mean ± s.d. *P < 0.05. (b) Cell viability. 
 
Figure 4. Optical (a) and confocal (b) microscopy images of an EFK8-SWNT hydrogel prepared within 
an EFK8 hydrogel. Z-stack images (c,d) obtained at different angles show the 3-dimensional structure of 
the cells within the hybrid hydrogel.  
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Figure 5. 3D cells after day one, three and five after encapsulation in EFK8 (a-c) and EFK8-SWNT (d-f) 
hydrogels, respectively.  
 
Figure 6. (a) Compressive modulus of various hydrogels. (b) Optical image of NIH-3T3 cells after 5 days 
of seeding on EFK8 hydrogel formed from peptide at concentration 5 mg ml−1 (scale bar: 400 µm).  
 
Figure 7. Optical images showing the evolution of A549 lung cancer cells seeded on different hydrogels 
from Day 4 to Day 12. Left column: Formation of spheroidal colonies of cancer cells induced by seeding 
on an EFK8 hydrogel formed from 1.25 mg ml−1 peptide. Middle column: Evidence of cancer cell 
movement after seeding on EFK8 hydrogel formed from 5 mg ml−1 peptide. Right column: Evidence of 
cancer cell movement after seeding on EFK8-SWNT hybrid hydrogel formed from 1.25 mg ml−1 peptide 
(scale bar: 200 µm). 
 
Figure 8. Staining A549 lung cancer cells using Calcein AM on (a) EFK8 hydrogel and (b) EFK8 (5 mg 
ml−1) hydrogel. In (a) green color of Calcein AM is replaced with a spectrum of different colors that 
represent different distances from the hydrogel surface. Immunostaining of A549 cells for β-catenin 
(green) and nucleus (blue) on (c) EFK8, (d) EFK8 (5 mg ml−1) and (e) EFK8-SWNT hydrogels. Scale bar 
is 20 µm. 
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Statement of Significance 
1- For the first time we used hybrid self-assembling peptide-carbon nanotube hybrid 
hydrogels (that we have recently introduced briefly in the "Carbon" journal in 2014) for 
tissue engineering and 3D tumor engineering. 
2- We showed the potential of these hybrid hydrogels to enhance the efficiency of the 
peptide hydrogels for tissue engineering application in terms of cell behavior (cell 
attachment, spreading and migration). This opens up new rooms for the peptide 
hydrogels and can expand their applications. 
3- Also our system (peptide and peptide-CNT hydrogels) was used for cancer cell spheroid 
formation showing the effect of both tumor microenvironment stiffness and cell-scaffold 
adhesion on cancer cell invasion. This was only possible based on the presence of 
CNTs in the hydrogel while the stiffness kept constant. 
4- Finally it should be noted that these hybrid hydrogels expand applications of peptide 
hydrogels through enhancing their capabilities and/or adding new properties to them. 
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